
    
      This is a Phase 1, randomized, double-blind, placebo-controlled, sequential-group
      administration of a new oral pentamidine formulation to investigate its hepatic uptake,
      pharmacokinetics, safety and tolerance in subjects with hepatocellular carcinoma who
      undergoes thermal ablation procedure
    
  